No. of Pages: 188 | Report Code: BMIRE00025068 | Category: Life Sciences
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 MEA Dermatology OTC Medications Market – By Product Type
1.3.2 MEA Dermatology OTC Medications Market – By Route of Administration
1.3.3 MEA Dermatology OTC Medications Market – By Indication
1.3.4 MEA Dermatology OTC Medications Market – By Distribution Channel
1.3.5 MEA Dermatology OTC Medications Market – By Country
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4.1 Overview
4.2 MEA PEST Analysis
4.3 Experts Opinion
5.1 Key Market Drivers
5.1.1 Surging Prevalence of Skin Problems
5.1.2 Escalating Income of Middle-class Population
5.2 Market Restraints
5.2.1 Inappropriate Use of OTC Medications
5.3 Market Opportunities
5.3.1 Accentuating OTC Market Across Various Countries
5.4 Future Trends
5.4.1 Burgeoning Transition from Rx to OTC
5.5 Impact Analysis of Drivers and Restraints
6.1 MEA Dermatology OTC Medications Market Revenue Forecast and Analysis
7.1 Overview
7.2 MEA Dermatology OTC Medications Market Share by Product Type, 2021 & 2028 (%)
7.3 Tablets and Capsules
7.3.1 Overview
7.3.2 Tablets and Capsules Market Revenue and Forecast to 2028 (US$ million)
7.4 Gels
7.4.1 Overview
7.4.2 Gels Market Revenue and Forecast to 2028 (US$ million)
7.5 Creams and Ointments
7.5.1 Overview
7.5.2 Creams and Ointments Market Revenue and Forecast to 2028 (US$ million)
7.6 Others
7.6.1 Overview
7.6.2 Others Market Revenue and Forecast to 2028 (US$ million)
8.1 Overview
8.2 MEA Dermatology OTC Medications Market Share, by Route of Administration, 2021 and 2028 (%)
8.3 Topical
8.3.1 Overview
8.3.2 Topical: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)
8.4 Oral
8.4.1 Overview
8.4.2 Oral: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)
9.1 Overview
9.2 MEA Dermatology OTC Medications Market Share, by Indication, 2021 and 2028 (%)
9.3 Dermatitis
9.3.1 Overview
9.3.2 Dermatitis: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)
9.3.3 Atopic Dermatitis
9.3.3.1 Overview
9.3.3.2 Atopic Dermatitis: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)
9.3.4 Contact Dermatitis
9.3.4.1 Overview
9.3.4.2 Contact Dermatitis: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)
9.3.5 Others
9.3.5.1 Overview
9.3.5.2 Others: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)
9.4 Acne
9.4.1 Overview
9.4.2 Acne: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)
9.4.3 Non-Inflammatory Acne
9.4.3.1 Overview
9.4.3.2 Non-Inflammatory Acne: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)
9.4.4 Inflammatory Acne
9.4.4.1 Overview
9.4.4.2 Inflammatory Acne: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)
9.5 Psoriasis
9.5.1 Overview
9.5.2 Psoriasis: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)
9.5.3 Plaque Psoriasis
9.5.3.1 Overview
9.5.3.2 Plaque Psoriasis: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)
9.5.4 Guttate Psoriasis
9.5.4.1 Overview
9.5.4.2 Guttate Psoriasis: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)
9.5.5 Others
9.5.5.1 Overview
9.5.5.2 Others: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)
9.6 Skin Bleaching
9.6.1 Overview
9.6.2 Skin Bleaching: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)
9.7 Fungal Disease
9.7.1 Overview
9.7.2 Fungal Disease: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)
9.7.3 Athlete's Foot
9.7.3.1 Overview
9.7.3.2 Athlete's Foot: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)
9.7.4 Ringworm
9.7.4.1 Overview
9.7.4.2 Ringworm: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)
9.7.5 Fungal Nail Infections
9.7.5.1 Overview
9.7.5.2 Fungal Nail Infections: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)
9.7.6 Others
9.7.6.1 Overview
9.7.6.2 Others: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)
9.8 Warts
9.8.1 Overview
9.8.2 Warts: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)
9.8.3 Common Warts
9.8.3.1 Overview
9.8.3.2 Common Warts: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)
9.8.4 Flat Warts
9.8.4.1 Overview
9.8.4.2 Flat Warts: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)
9.8.5 Others
9.8.5.1 Overview
9.8.5.2 Others: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)
9.9 Others
9.9.1 Overview
9.9.2 Others: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)
10.1 Overview
10.2 MEA Dermatology OTC Medications Market Share, by Distribution Channel, 2021 and 2028 (%)
10.3 Online Distribution
10.3.1 Overview
10.3.2 Online Distribution: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)
10.4 Offline Distribution
10.4.1 Overview
10.4.2 Offline Distribution: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)
10.4.3 Retail and Hospital Pharmacies
10.4.3.1 Overview
10.4.3.2 Retail and Hospital Pharmacies: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)
10.4.4 Super and Hyper Markets
10.4.4.1 Overview
10.4.4.2 Super and Hyper Markets: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)
11.1 MEA Medical Lasers Market Revenue and Forecasts To 2028
11.1.1 Overview
11.1.2 MEA Dermatology OTC Medications Market Revenue and Forecasts to 2028, By Country (%)
11.1.3 UAE: Dermatology OTC Medications Market Revenue and Forecasts to 2028 (US$ Million)
11.1.3.1 UAE: Dermatology OTC Medications Market Revenue and Forecasts to 2028 (US$ Million)
11.1.3.2 UAE: Dermatology OTC Medications Market, by Product Type, 2019–2028 (USD Million)
11.1.3.3 UAE: Dermatology OTC Medications Market, By Route of Administration,2019–2028 (USD Million)
11.1.3.4 UAE: Dermatology OTC Medications Market, By Indication, 2019–2028 (USD Million)
11.1.3.4.1 UAE: Dermatology OTC Medications Market, by Acne Indication, 2019–2028 (USD Million)
11.1.3.4.2 UAE: Dermatology OTC Medications Market, by Dermatitis Indication, 2019–2028 (USD Million)
11.1.3.4.3 UAE: Dermatology OTC Medications Market, by Fungal Diseases Indication, 2019–2028 (USD Million)
11.1.3.4.4 UAE: Dermatology OTC Medications Market, by Psoriasis Indication, 2019–2028 (USD Million)
11.1.3.4.5 UAE: Dermatology OTC Medications Market, by Warts Indication, 2019–2028 (USD Million)
11.1.3.5 UAE: Dermatology OTC Medications Market, By Distribution Channel, 2019–2028 (USD Million)
11.1.3.5.1 UAE: Dermatology OTC Medications Market, by Offline Distribution, 2019–2028 (USD Million)
11.1.4 Saudi Arabia: Dermatology OTC Medications Market Revenue and Forecasts to 2028 (US$ Million)
11.1.4.1 Saudi Arabia: Dermatology OTC Medications Market Revenue and Forecasts to 2028 (US$ Million)
11.1.4.2 Saudi Arabia: Dermatology OTC Medications Market, by Product Type, 2019–2028 (USD Million)
11.1.4.3 Saudi Arabia: Dermatology OTC Medications Market, By Route of Administration,2019–2028 (USD Million)
11.1.4.4 Saudi Arabia: Dermatology OTC Medications Market, By Indication, 2019–2028 (USD Million)
11.1.4.4.1 Saudi Arabia: Dermatology OTC Medications Market, by Acne Indication, 2019–2028 (USD Million)
11.1.4.4.2 Saudi Arabia: Dermatology OTC Medications Market, by Dermatitis Indication, 2019–2028 (USD Million)
11.1.4.4.3 Saudi Arabia: Dermatology OTC Medications Market, by Fungal Diseases Indication, 2019–2028 (USD Million)
11.1.4.4.4 Saudi Arabia: Dermatology OTC Medications Market, by Psoriasis Indication, 2019–2028 (USD Million)
11.1.4.4.5 Saudi Arabia: Dermatology OTC Medications Market, by Warts Indication, 2019–2028 (USD Million)
11.1.4.5 Saudi Arabia: Dermatology OTC Medications Market, By Distribution Channel, 2019–2028 (USD Million)
11.1.4.5.1 Saudi Arabia: Dermatology OTC Medications Market, by Offline Distribution, 2019–2028 (USD Million)
11.1.5 South Africa: Dermatology OTC Medications Market Revenue and Forecasts to 2028 (US$ Million)
11.1.5.1 South Africa Dermatology OTC Medications Market Revenue and Forecasts to 2028 (US$ Million)
11.1.5.2 South Africa: Dermatology OTC Medications Market, by Product Type, 2019–2028 (USD Million)
11.1.5.3 South Africa: Dermatology OTC Medications Market, By Route of Administration,2019–2028 (USD Million)
11.1.5.4 South Africa: Dermatology OTC Medications Market, By Indication, 2019–2028 (USD Million)
11.1.5.4.1 South Africa: Dermatology OTC Medications Market, by Acne Indication, 2019–2028 (USD Million)
11.1.5.4.2 South Africa: Dermatology OTC Medications Market, by Dermatitis Indication, 2019–2028 (USD Million)
11.1.5.4.3 South Africa: Dermatology OTC Medications Market, by Fungal Diseases Indication, 2019–2028 (USD Million)
11.1.5.4.4 South Africa: Dermatology OTC Medications Market, by Psoriasis Indication, 2019–2028 (USD Million)
11.1.5.4.5 South Africa: Dermatology OTC Medications Market, by Warts Indication, 2019–2028 (USD Million)
11.1.5.5 South Africa: Dermatology OTC Medications Market, By Distribution Channel, 2019–2028 (USD Million)
11.1.5.5.1 South Africa: Dermatology OTC Medications Market, by Offline Distribution, 2019–2028 (USD Million)
11.1.6 Rest of the MEA: Dermatology OTC Medications Market Revenue and Forecasts to 2028 (US$ Million)
11.1.6.1 Rest of MEA: Dermatology OTC Medications Market Revenue and Forecasts to 2028 (US$ Million)
11.1.6.2 Rest of MEA: Dermatology OTC Medications Market, by Product Type, 2019–2028 (USD Million)
11.1.6.3 Rest of MEA: Dermatology OTC Medications Market, By Route of Administration,2019–2028 (USD Million)
11.1.6.4 Rest of MEA: Dermatology OTC Medications Market, By Indication, 2019–2028 (USD Million)
11.1.6.4.1 Rest of MEA: Dermatology OTC Medications Market, by Acne Indication, 2019–2028 (USD Million)
11.1.6.4.2 Rest of MEA: Dermatology OTC Medications Market, by Dermatitis Indication, 2019–2028 (USD Million)
11.1.6.4.3 Rest of MEA: Dermatology OTC Medications Market, by Fungal Diseases Indication, 2019–2028 (USD Million)
11.1.6.4.4 Rest of MEA: Dermatology OTC Medications Market, by Psoriasis Indication, 2019–2028 (USD Million)
11.1.6.4.5 Rest of MEA: Dermatology OTC Medications Market, by Warts Indication, 2019–2028 (USD Million)
11.1.6.5 Rest of MEA: Dermatology OTC Medications Market, By Distribution Channel, 2019–2028 (USD Million)
11.1.6.5.1 Rest of Middle East and Africa: Dermatology OTC Medications Market, by Offline Distribution, 2019–2028 (USD Million)
12.1 Overview
12.2 Inorganic Growth Strategies
12.2.1 Overview
12.3 Organic Growth Strategies
12.3.1 Overview
13.1 Bausch Health Companies Inc.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Perrigo Company plc
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Bayer AG
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Viatris Inc.
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Johnson and Johnson Services, Inc.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 LEO Pharma A/S
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 GlaxoSmithKline plc.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Galderma
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Dr. Reddy's Laboratories
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
14.1 Glossary of Terms
Table 1. MEA Dermatology OTC Medications Market, Revenue and Forecast, 2019–2028 (US$ Mn)
Table 2. UAE: Dermatology OTC Medications Market, by Product Type – Revenue and Forecast to 2028 (USD Million)
Table 3. UAE: Dermatology OTC Medications Market, By Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 4. UAE: Dermatology OTC Medications Market, By Indication – Revenue and Forecast to 2028 (USD Million)
Table 5. UAE: Dermatology OTC Medications Market, by Acne Indication – Revenue and Forecast to 2028 (USD Million)
Table 6. UAE: Dermatology OTC Medications Market, by Dermatitis Indication – Revenue and Forecast to 2028 (USD Million).
Table 7. UAE: Dermatology OTC Medications Market, by Fungal Diseases Indication – Revenue and Forecast to 2028 (USD Million)
Table 8. UAE: Dermatology OTC Medications Market, by Psoriasis Indication – Revenue and Forecast to 2028 (USD Million)
Table 9. UAE: Dermatology OTC Medications Market, by Warts Indication – Revenue and Forecast to 2028 (USD Million)
Table 10. UAE: Dermatology OTC Medications Market, By Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 11. UAE: Dermatology OTC Medications Market, by Offline Distribution – Revenue and Forecast to 2028 (USD Million)
Table 12. Saudi Arabia: Dermatology OTC Medications Market, by Product Type – Revenue and Forecast to 2028 (USD Million)
Table 13. Saudi Arabia: Dermatology OTC Medications Market, By Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 14. Saudi Arabia: Dermatology OTC Medications Market, By Indication – Revenue and Forecast to 2028 (USD Million)
Table 15. Saudi Arabia: Dermatology OTC Medications Market, by Acne Indication – Revenue and Forecast to 2028 (USD Million)
Table 16. Saudi Arabia: Dermatology OTC Medications Market, by Dermatitis Indication – Revenue and Forecast to 2028 (USD Million)
Table 17. Saudi Arabia: Dermatology OTC Medications Market, by Fungal Diseases Indication – Revenue and Forecast to 2028 (USD Million)
Table 18. Saudi Arabia: Dermatology OTC Medications Market, by Psoriasis Indication – Revenue and Forecast to 2028 (USD Million)
Table 19. Saudi Arabia: Dermatology OTC Medications Market, by Warts Indication – Revenue and Forecast to 2028 (USD Million)
Table 20. Saudi Arabia: Dermatology OTC Medications Market, By Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 21. Saudi Arabia: Dermatology OTC Medications Market, by Offline Distribution – Revenue and Forecast to 2028 (USD Million)
Table 22. South Africa: Dermatology OTC Medications Market, by Product Type – Revenue and Forecast to 2028 (USD Million)
Table 23. South Africa: Dermatology OTC Medications Market, By Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 24. South Africa: Dermatology OTC Medications Market, By Indication – Revenue and Forecast to 2028 (USD Million)
Table 25. South Africa: Dermatology OTC Medications Market, by Acne Indication – Revenue and Forecast to 2028 (USD Million)
Table 26. South Africa: Dermatology OTC Medications Market, by Dermatitis Indication – Revenue and Forecast to 2028 (USD Million)
Table 27. South Africa: Dermatology OTC Medications Market, by Fungal Diseases Indication – Revenue and Forecast to 2028 (USD Million)
Table 28. South Africa: Dermatology OTC Medications Market, by Psoriasis Indication – Revenue and Forecast to 2028 (USD Million)
Table 29. South Africa: Dermatology OTC Medications Market, by Warts Indication – Revenue and Forecast to 2028 (USD Million)
Table 30. South Africa: Dermatology OTC Medications Market, By Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 31. South Africa: Dermatology OTC Medications Market, by Offline Distribution – Revenue and Forecast to 2028 (USD Million)
Table 32. Rest of MEA: Dermatology OTC Medications Market, by Product Type – Revenue and Forecast to 2028 (USD Million)
Table 33. Rest of MEA: Dermatology OTC Medications Market, By Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 34. Rest of MEA: Dermatology OTC Medications Market, By Indication – Revenue and Forecast to 2028 (USD Million)
Table 35. Rest of MEA: Dermatology OTC Medications Market, by Acne Indication – Revenue and Forecast to 2028 (USD Million)
Table 36. Rest of MEA: Dermatology OTC Medications Market, by Dermatitis Indication – Revenue and Forecast to 2028 (USD Million)
Table 37. Rest of MEA: Dermatology OTC Medications Market, by Fungal Diseases Indication – Revenue and Forecast to 2028 (USD Million)
Table 38. Rest of MEA: Dermatology OTC Medications Market, by Psoriasis Indication – Revenue and Forecast to 2028 (USD Million)
Table 39. Rest of MEA: Dermatology OTC Medications Market, by Warts Indication – Revenue and Forecast to 2028 (USD Million)
Table 40. Rest of MEA: Dermatology OTC Medications Market, By Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 41. Rest of Middle East and Africa: Dermatology OTC Medications Market, by Offline Distribution – Revenue and Forecast to 2028 (USD Million)
Table 42. Recent Inorganic Growth Strategies
Table 43. Recent Organic Growth Strategies
Table 44. Glossary of Terms
Figure 1. MEA Dermatology OTC Medications Market Segmentation
Figure 2. MEA Dermatology OTC Medications Market, By Country
Figure 3. MEA Dermatology OTC Medications Market Overview
Figure 4. Creams and Ointments Segment Held the Largest Share of the Market in 2021
Figure 5. South Africa held the Largest Share of the Market in 2021
Figure 6. MEA: PEST Analysis
Figure 7. Experts Opinion
Figure 8. MEA Dermatology OTC Medications Market Impact Analysis of Drivers and Restraints
Figure 9. MEA Dermatology OTC Medications Market – By Forecast and Analysis
Figure 10. MEA Dermatology OTC Medications Market Share by Product Type, 2021 & 2028 (%)
Figure 11. MEA Tablets and Capsules Market Revenue and Forecasts to 2028 (US$ million)
Figure 12. MEA Gels Market Revenue and Forecasts to 2028 (US$ million)
Figure 13. MEA Creams and Ointments Market Revenue and Forecasts to 2028 (US$ million)
Figure 14. MEA Others Market Revenue and Forecasts to 2028 (US$ million)
Figure 15. MEA Dermatology OTC Medications market Share, by Route of Administration, 2021 and 2028 (%)
Figure 16. MEA Topical: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)
Figure 17. MEA Oral: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)
Figure 18. MEA Dermatology OTC Medications Market Share, by Indication, 2021 and 2028 (%)
Figure 19. MEA Dermatitis: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)
Figure 20. MEA Atopic Dermatitis: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)
Figure 21. MEA Contact Dermatitis: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)
Figure 22. MEA Others: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)
Figure 23. MEA Acne: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)
Figure 24. MEA Non-Inflammatory Acne: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)
Figure 25. MEA Inflammatory Acne: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)
Figure 26. MEA Psoriasis: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)
Figure 27. MEA Plaque Psoriasis: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)
Figure 28. MEA Guttate Psoriasis: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)
Figure 29. MEA Others: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)
Figure 30. MEA Skin Bleaching: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)
Figure 31. MEA Fungal Disease: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)
Figure 32. MEA Athlete's Foot: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)
Figure 33. MEA Ringworm: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)
Figure 34. MEA Fungal Nail Infections: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)
Figure 35. MEA Others: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)
Figure 36. MEA Warts: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)
Figure 37. MEA Common Warts: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)
Figure 38. MEA Flat Warts: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)
Figure 39. MEA Others: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)
Figure 40. MEA Others: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)
Figure 41. MEA Dermatology OTC Medications market Share, by Distribution Channel, 2021 and 2028 (%)
Figure 42. MEA Online Distribution: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)
Figure 43. MEA Offline Distribution: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)
Figure 44. MEA Retail and Hospital Pharmacies: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)
Figure 45. MEA Super and Hyper Markets: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)
Figure 46. MEA Dermatology OTC Medications Market Revenue Overview, by Country, 2021 (US$ Million)
Figure 47. MEA Dermatology OTC Medications Market Revenue and Forecasts to 2028, By Country (%)
Figure 48. UAE: Dermatology OTC Medications Market Revenue and Forecasts to 2028 (US$ Million)
Figure 49. Saudi Arabia: Dermatology OTC Medications Market Revenue and Forecasts to 2028 (US$ Million)
Figure 50. South Africa: Dermatology OTC Medications Market Revenue and Forecasts to 2028 (US$ Million)
Figure 51. Rest of MEA: Dermatology OTC Medications Market Revenue and Forecasts to 2028 (US$ Million)
E 1803, Panchshil Towers, Vagholi, Haveli, Pune- 412207, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Middle East & Africa Dermatology OTC Medications Market
